查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2026861

皮下給藥裝置市場預測至2034年－按產品類型、類別、適應症、通路和地區分類的全球分析

Subcutaneous Drug Delivery Devices Market Forecasts to 2034 - Global Analysis By Product, Type, Indication, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球皮下給藥設備市場規模將達到 426 億美元，並在預測期內以 11.3% 的複合年成長率成長，到 2034 年將達到 1002 億美元。

皮下給藥醫療設備器材。這種給藥方式優於其他方式，因為它能夠使藥物持續穩定地釋放到血液中，從而減少副作用並提供更穩定的治療效果。皮下給藥系統由注射器、給藥裝置和藥物容器組成，這些零件均植入皮下。

據美國多發性硬化症協會稱，截至 2017 年，美國估計有 100 萬成年人患有多發性硬化症。

慢性病增多

糖尿病、自體免疫疾病和心血管疾病等慢性病的日益普遍，推動了對皮下給藥裝置的需求。這些裝置為長期控制這些疾病的用藥提供了一個有效的途徑。因此，慢性病盛行率的快速成長預計將推動市場成長。

缺乏健康意識

在新興和開發中國家，人們對藥物、各種疾病以及給藥技術缺乏了解。醫療設施不足導致慢性病相關死亡人數上升。許多農村居民仍然無法獲得診斷和治療。此外，在許多國家，藥品和給藥裝置的高成本限制了皮下給藥裝置的使用。這是一個可能阻礙市場擴張的重要因素。

對生物相似藥和生物製藥的需求不斷成長

由於生物製藥和生物相似藥的快速發展，全球皮下給藥裝置市場的參與企業正面臨許多成長機會。治療慢性疾病所需的各種藥物需求不斷成長，推動了全球對皮下給藥系統的需求。生物製藥和生物相似藥（通常需要皮下給藥）的廣泛應用，也帶動了對專為這些藥物設計的給藥裝置的需求。

使用不當可能導致針刺傷。

針刺傷和藥物過量只是因缺乏充分資訊和指導而錯誤使用皮下注射裝置所導致的諸多問題中的幾個例子。這會使患者更難從多種給藥方式中選擇合適的方案。此外，注射針頭相關的血液傳染感染風險也可能構成重大威脅。

新冠疫情的感染疾病：

與整個醫療產業一樣，皮下給藥裝置市場也受到了新冠疫情的顯著影響。居家照護和遠端醫療的日益普及，以及由此導致的醫院就診量減少，推動了對可自行給藥裝置的需求成長。此次疫情凸顯了高效給藥技術的重要性，並促進了皮下給藥裝置的創新和投資。

在預測期內，穿戴式注射器細分市場預計將成為最大的細分市場。

在預測期內，穿戴式注射器市場預計將佔據最大佔有率。這與針刺傷事件的增加以及注射相關血液傳播疾病風險的上升密切相關。高黏度、大容量的生物製藥可透過穿戴式注射器高效給藥。這些被稱為穿戴式注射器的數位給藥工具，不僅方便快捷，還能幫助患者在正確的時間注射正確的劑量。

在預測期內，神經系統疾病領域預計將呈現最高的複合年成長率。

預計在預測期內，神經系統疾病領域將呈現最高的複合年成長率。這些設備能夠以可控且穩定的方式長期釋放藥物。對於癲癇和帕金森氏症等藥物濃度穩定的神經系統疾病，這種控釋方式有助於有效控制症狀。這些設備的設計通常以患者舒適度為首要考慮因素，力求最大限度地減少治療的侵入性。

市佔率最大的地區：

由於各種慢性病盛行率的上升，北美人口對藥品和給藥設備的需求激增，預計北美將在預測期內佔據最大的市場佔有率。推動這一市場成長的關鍵因素包括：醫療基礎設施的不斷改善、該地區多家大型製造商各自採用不同的發展策略，以及醫療保健支出的不斷成長。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率。這主要是由於該地區糖尿病患者人數的快速成長，而這又歸因於人們不健康的飲食習慣。可支配收入的增加、糖尿病管理意識的提高以及醫療保健支出的成長，將是近期市場成長的主要驅動力。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球皮下給藥裝置市場：依產品分類

  • 預填充式注射器
  • 自動注射器
  • 穿戴式注射器
  • 筆式注射器
  • 無針注射器
  • 其他產品

第6章 全球皮下給藥裝置市場：依類型分類

  • 一次性的
  • 可重複使用的

第7章 全球皮下給藥裝置市場：依適應症分類

  • 神經系統疾病
  • 腫瘤疾病
  • 自體免疫疾病
  • 眼科疾病
  • 過敏及感染疾病
  • 內分泌疾病
  • 其他改編

第8章：全球皮下給藥裝置市場：依分銷管道分類

  • 醫院
  • 零售藥房
  • 網路藥房
  • 其他分銷管道

第9章 全球皮下給藥裝置市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Medtronic Plc
  • Gerresheimer AG
  • Elcam Medical Group
  • Insulet Corporation
  • Ypsomed AG
  • Becton, Dickinson and Company
  • PharmaJet
  • Unilife Corporation
  • In life Sciences
  • West Pharmaceutical Services, Inc.
  • Novo Nordisk
  • Eli Lilly
  • Merck
  • AstraZeneca
  • Amgen
  • Enable Injections
  • Consort Medical Plc
  • Wilhelm Haselmeier GmbH & Co. KG
Product Code: SMRC24650

According to Stratistics MRC, the Global Subcutaneous Drug Delivery Devices Market is accounted for $42.6 billion in 2026 and is expected to reach $100.2 billion by 2034 growing at a CAGR of 11.3% during the forecast period. Medical equipment called subcutaneous drug delivery devices is used to give patients medication subcutaneously, or under the skin. This method of drug delivery is preferred over others because it enables the drug's constant and continuous release into circulation, leading to less side effects and more consistent therapeutic advantages. Subcutaneous drug delivery systems consist of a syringe inserted under the skin, a distribution system, and a pharmaceutical container.

According to the National Multiple Sclerosis Society, an estimated 1.0 million adults were reported to be living with multiple sclerosis in the U.S. in 2017.

Market Dynamics:

Driver:

Rise in Chronic Diseases

Increasing prevalence of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions has driven the demand for subcutaneous drug delivery devices. These devices offer an effective way to administer medication for long-term management of these ailments. Therefore, the rapidly growing prevalence of chronic diseases is expected to drive the growth of the market.

Restraint:

Lack of health awareness

In emerging and undeveloped economies, there's a dearth of knowledge about pharmaceuticals, various ailments, and drug delivery technologies. Chronic illness-related fatalities rise as a result of inadequate healthcare facilities. Most rural residents continue to go undetected and untreated. Furthermore, the use of subcutaneous drug delivery devices is limited in a number of countries by the high cost of medications and drug administration equipment. This is a significant element that might impede market expansion.

Opportunity:

Growing demand for biosimilar and biologics

The market participants in the worldwide subcutaneous drug delivery devices market have a number of growth opportunities thanks to the quick rise in popularity of biologic and biosimilar medications. Global demand for subcutaneous drug delivery systems is being driven by the increasing need for different medications to treat chronic conditions. The growing use of biologics and biosimilars, which often require subcutaneous administration, has bolstered the demand for specialized delivery devices tailored for these medications.

Threat:

Improper use may give rise to needle stick injuries

Needlestick injuries and drug overdoses are only two of the issues that can arise from using subcutaneous medication delivery devices improperly without the right information and instruction. This can make it more difficult for the patients to choose between several drug delivery options. Furthermore, the dangers of blood-borne infections linked to injection needles might end up being a significant obstacle.

Covid-19 Impact:

The market for subcutaneous medication delivery devices has been significantly impacted by the COVID-19 epidemic, as has the whole healthcare sector. Self-administration devices are becoming more and more in demand as a result of the growing emphasis on home-based treatment, remote healthcare, and reducing hospital visits. The epidemic has brought attention to the significance of efficient medication delivery techniques, spurring innovation and investment in the subcutaneous drug delivery market.

The wearable injectors segment is expected to be the largest during the forecast period

The wearable injectors segment is expected to be the largest during the forecast period. This is linked to the increase in needle stick injuries as well as the increased risk of blood-borne illnesses from injection usage. The high-viscosity, high-volume biologic medications are administered with exceptional efficiency by the wearable injectors. Digital medicine administration tools called wearable injectors are convenient and assist patients in giving precise dosages at the appropriate times.

The neurological disorders segment is expected to have the highest CAGR during the forecast period

The neurological disorders segment is expected to have the highest CAGR during the forecast period. These devices can provide a controlled and steady release of medications over an extended period. For neurological disorders where consistent medication levels are crucial, such as in epilepsy or Parkinson's disease, this controlled release can help manage symptoms effectively. These devices are often designed for patient comfort, minimizing the invasiveness of treatments.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the increased prevalence of various chronic diseases resulted in the huge demand for drugs and drug delivery devices amongst the population. The market is growing due to a number of significant reasons, including the presence of improved healthcare infrastructure, the presence of multiple major manufacturers in the region and the different developmental strategies they have followed, and rising healthcare spending.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. This is majorly attributed to the rapidly growing diabetic population in the region owing to the unhealthy food habits of the people. The rising disposable income, growing awareness regarding the diabetes management, and rising healthcare expenditure are the major factors that will drive the growth of the market in the forthcoming future.

Key players in the market

Some of the key players in Subcutaneous Drug Delivery Devices market include Medtronic Plc, Gerresheimer AG, Elcam Medical Group, Insulet Corporation, Ypsomed AG, Becton, Dickinson and Company, PharmaJet, Unilife Corporation, In life Sciences , West Pharmaceutical Services, Inc., Novo Nordisk, Eli Lilly, Merck, AstraZeneca, Amgen, Enable Injections, Consort Medical Plc and Wilhelm Haselmeier GmbH & Co. KG.

Key Developments:

In November 2023, The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's Zepbound(TM) (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.

In October 2023, Eli Lilly gives $20M upfront cash injection to Elektrofi in next-gen subcutaneous drug collab. Eli Lilly has tapped up drug delivery specialist Elektrofi to see whether the biotech's microparticle formulation technology could produce the next generation of subcutaneously administered therapies.

Products Covered:

  • Prefilled Syringes
  • Auto-Injectors
  • Wearable Injectors
  • Pen Injectors
  • Needle-Free Injectors
  • Other Products

Types Covered:

  • Disposable
  • Reusable

Indications Covered:

  • Neurological Disorders
  • Oncology Disorders
  • Auto-immune Disorders
  • Ophthalmic Disorders
  • Allergy & Infectious Disorders
  • Hormonal Disorders
  • Other Indications

Distribution Channels Covered:

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Subcutaneous Drug Delivery Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Prefilled Syringes
  • 5.3 Auto-Injectors
  • 5.4 Wearable Injectors
  • 5.5 Pen Injectors
  • 5.6 Needle-Free Injectors
  • 5.7 Other Products

6 Global Subcutaneous Drug Delivery Devices Market, By Type

  • 6.1 Introduction
  • 6.2 Disposable
  • 6.3 Reusable

7 Global Subcutaneous Drug Delivery Devices Market, By Indication

  • 7.1 Introduction
  • 7.2 Neurological Disorders
  • 7.3 Oncology Disorders
  • 7.4 Auto-immune Disorders
  • 7.5 Ophthalmic Disorders
  • 7.6 Allergy & Infectious Disorders
  • 7.7 Hormonal Disorders
  • 7.8 Other Indications

8 Global Subcutaneous Drug Delivery Devices Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Retail Pharmacies
  • 8.4 Online Pharmacies
  • 8.5 Other Distribution Channels

9 Global Subcutaneous Drug Delivery Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic Plc
  • 11.2 Gerresheimer AG
  • 11.3 Elcam Medical Group
  • 11.4 Insulet Corporation
  • 11.5 Ypsomed AG
  • 11.6 Becton, Dickinson and Company
  • 11.7 PharmaJet
  • 11.8 Unilife Corporation
  • 11.9 In life Sciences
  • 11.10 West Pharmaceutical Services, Inc.
  • 11.11 Novo Nordisk
  • 11.12 Eli Lilly
  • 11.13 Merck
  • 11.14 AstraZeneca
  • 11.15 Amgen
  • 11.16 Enable Injections
  • 11.17 Consort Medical Plc
  • 11.18 Wilhelm Haselmeier GmbH & Co. KG

List of Tables

  • Table 1 Global Subcutaneous Drug Delivery Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023-2034) ($MN)
  • Table 4 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023-2034) ($MN)
  • Table 5 Global Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023-2034) ($MN)
  • Table 6 Global Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023-2034) ($MN)
  • Table 7 Global Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023-2034) ($MN)
  • Table 8 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 9 Global Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023-2034) ($MN)
  • Table 10 Global Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 11 Global Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 12 Global Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023-2034) ($MN)
  • Table 13 Global Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 14 Global Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023-2034) ($MN)
  • Table 15 Global Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023-2034) ($MN)
  • Table 16 Global Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023-2034) ($MN)
  • Table 17 Global Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023-2034) ($MN)
  • Table 18 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023-2034) ($MN)
  • Table 19 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023-2034) ($MN)
  • Table 20 Global Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 21 Global Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 22 Global Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 23 Global Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 24 Global Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 25 North America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 26 North America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 27 North America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023-2034) ($MN)
  • Table 28 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023-2034) ($MN)
  • Table 29 North America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023-2034) ($MN)
  • Table 30 North America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023-2034) ($MN)
  • Table 31 North America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023-2034) ($MN)
  • Table 32 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 33 North America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023-2034) ($MN)
  • Table 34 North America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 35 North America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 36 North America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023-2034) ($MN)
  • Table 37 North America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 38 North America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023-2034) ($MN)
  • Table 39 North America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023-2034) ($MN)
  • Table 40 North America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023-2034) ($MN)
  • Table 41 North America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023-2034) ($MN)
  • Table 42 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023-2034) ($MN)
  • Table 43 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023-2034) ($MN)
  • Table 44 North America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 45 North America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 46 North America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 47 North America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 48 North America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 49 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 50 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 51 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023-2034) ($MN)
  • Table 52 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023-2034) ($MN)
  • Table 53 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023-2034) ($MN)
  • Table 54 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023-2034) ($MN)
  • Table 55 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023-2034) ($MN)
  • Table 56 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 57 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023-2034) ($MN)
  • Table 58 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 59 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 60 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023-2034) ($MN)
  • Table 61 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 62 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023-2034) ($MN)
  • Table 63 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023-2034) ($MN)
  • Table 64 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023-2034) ($MN)
  • Table 65 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023-2034) ($MN)
  • Table 66 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023-2034) ($MN)
  • Table 67 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023-2034) ($MN)
  • Table 68 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 69 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 70 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 71 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 72 Europe Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 73 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 74 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 75 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023-2034) ($MN)
  • Table 76 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023-2034) ($MN)
  • Table 77 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023-2034) ($MN)
  • Table 78 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023-2034) ($MN)
  • Table 79 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023-2034) ($MN)
  • Table 80 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 81 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023-2034) ($MN)
  • Table 82 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 83 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 84 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023-2034) ($MN)
  • Table 85 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 86 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023-2034) ($MN)
  • Table 87 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023-2034) ($MN)
  • Table 88 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023-2034) ($MN)
  • Table 89 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023-2034) ($MN)
  • Table 90 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023-2034) ($MN)
  • Table 91 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023-2034) ($MN)
  • Table 92 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 93 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 94 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 95 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 96 Asia Pacific Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 97 South America Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 98 South America Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 99 South America Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023-2034) ($MN)
  • Table 100 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023-2034) ($MN)
  • Table 101 South America Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023-2034) ($MN)
  • Table 102 South America Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023-2034) ($MN)
  • Table 103 South America Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023-2034) ($MN)
  • Table 104 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 105 South America Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023-2034) ($MN)
  • Table 106 South America Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 107 South America Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 108 South America Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023-2034) ($MN)
  • Table 109 South America Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 110 South America Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023-2034) ($MN)
  • Table 111 South America Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023-2034) ($MN)
  • Table 112 South America Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023-2034) ($MN)
  • Table 113 South America Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023-2034) ($MN)
  • Table 114 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023-2034) ($MN)
  • Table 115 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023-2034) ($MN)
  • Table 116 South America Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 117 South America Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 118 South America Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 119 South America Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 120 South America Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 121 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 122 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 123 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Prefilled Syringes (2023-2034) ($MN)
  • Table 124 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-Injectors (2023-2034) ($MN)
  • Table 125 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Wearable Injectors (2023-2034) ($MN)
  • Table 126 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Pen Injectors (2023-2034) ($MN)
  • Table 127 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Needle-Free Injectors (2023-2034) ($MN)
  • Table 128 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 129 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Type (2023-2034) ($MN)
  • Table 130 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Disposable (2023-2034) ($MN)
  • Table 131 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Reusable (2023-2034) ($MN)
  • Table 132 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Indication (2023-2034) ($MN)
  • Table 133 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Neurological Disorders (2023-2034) ($MN)
  • Table 134 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Oncology Disorders (2023-2034) ($MN)
  • Table 135 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Auto-immune Disorders (2023-2034) ($MN)
  • Table 136 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Ophthalmic Disorders (2023-2034) ($MN)
  • Table 137 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Allergy & Infectious Disorders (2023-2034) ($MN)
  • Table 138 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hormonal Disorders (2023-2034) ($MN)
  • Table 139 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Indications (2023-2034) ($MN)
  • Table 140 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 141 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 142 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 143 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 144 Middle East & Africa Subcutaneous Drug Delivery Devices Market Outlook, By Other Distribution Channels (2023-2034) ($MN)